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Physical exercise has been introduced as a provocation test
for early renal abnormalities in diabetes mellitus as well as in
hypertension, and it has been shown that both groups of
patients exhibit abnormal albumin excretion when exercise-
induced with moderate workloads [1—6]. However, the exact
relationship between exercise loads and abnormal albumin
excretion in diabetic patients has not been established. The
purpose of this study is to define more closely the importance of
work intensity on the renal response to exercise, in terms of
albumin excretion.
It is well-established that metabolic control in diabetes melli-
tus influences kidney function in terms of basal albumin excre-
tion and glomerular filtration rate (GFR) [7, 8]. This study also
includes an investigation concerning the importance of diabetic
control on exercise-induced albuminuria in diabetic patients.
Methods
Patients and healthy persons. In Table 1 are shown the
clinical data of 17 young men with insulin-dependent, non-
obese, juvenile diabetes mellitus and ten healthy control males.
Six of the diabetic patients were newly diagnosed and studied
during the start of insulin treatment, and 11 diabetic patients
were studied during graduated exercise as were the ten control
persons. The ten control persons were comparable with age,
sex, weight, and height to the 11 diabetics, who were examined
in their usual control situation. Mild retinopathy in the form of
red dots and dilated veins were found in two of the patients.
Procedure during exercise test. The six newly diagnosed
diabetic patients performed the exercise test both before and
after insulin treatment. In this exercise test 450 followed by 600
kpm/min 20 mm were used for each load, as described earlier
[2]. The patients were studied shortly after admission the day
before the beginning of insulin treatment and again after 6 to 15
days of treatment.
The 11 diabetic patients and 10 control persons were studied
during graduated exercise, which was performed on separate
occasions. They were each examined on 3 to 6 separate days
with intervals of 1 week to I month. On each day of examina-
tion two separate work loads of 20 mm each were undertaken
on a bicycle ergometer (Monark) as described earlier [21. On
each day two pre-exercise periods were followed by two
exercise periods and thereafter by two postexercise periods; all
periods were 20 mm each. The work loads were of 300 or 450
kpm/min for the first exercise period and of 600, 750, 900, or
1200 kpmlmin for the second exercise period.
Urine flow was increased by water drinking, 250 ml every 20
mm, starting 2 hr before the start of the pre-exercise period and
continuing throughout the test. Urine samples were collected
every 20 mm.
Heart rate and auscultatory BP were measured at regular
intervals three times during each of the two exercise periods
and during the second pre-exercise period. Only systolic pres-
sure was readily measurable during exercise.
Analytical methods. Urine excretion of albumin [9] and beta-
2-microglobulin (Phadebas beta-2-micro test) [101 were mea-
sured by radioimmunoassay. Ten .j.l of 20% bovine albumin
(Ortho Diagnostics) were added to 7-ml urine samples to
prevent the absorption of proteins to glass and plastic ware.
Statistical methods. Wilcoxon rank sum test, using Geigy
scientific tables, was used for statistical calculations of urinary
albumin and beta-2-microglobulin excretion and Student's t test
was applied to the hemodynamic data. Spearmans rank correla-
tion coefficient was used for the calculation of the correlation
between hemodynamic data and albumin excretion in the
graduated exercise test.
Results
Before and after insulin treatment
Protein excretion. Both at rest and during exercise the
albumin excretion was abnormally high before treatment as
shown in Table 2. The abnormal albumin response to the
exercise test as well as baseline values was normalized after 6 to
15 days of insulin treatment. The baseline mean values were
four times higher before treatment; exercise-induced values
were 12 times higher, compared to value after treatment.
Beta-2-microglobulin excretion (Table 3) was not increased
during exercise either before or after insulin treatment. The pre-
exercise values also showed no difference. One patient had a
very high excretion rate of beta-2-microglobulin before treat-
ment but was completely normalized after insulin treatment.
Before treatment his excretion rate increased during exercise
but after treatment he showed no increase either in beta-2-
microglobulin or in albumin excretion.
Hemodynamics. Heart rate before and after treatment was at
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Table 1. Study subjectsa
Group
Normal subjects
Diabetic patients
Diabetic patients
(newly diagnosed)
Age
N years
Duration of diabetes
mellitus
10.4 6.0 (4—21 yrs)
6—15 daysb
Plasma glucose
mg/lOU ml
174 50
254/160 14/57c
a Values are the means SD. Ranges are in parentheses. N denotes the number of subjects.
Duration of insulin treatment.
Before/after insulin treatment.
Table 2. Albumin excretion (ig/min) before and after insulin treatmenta
Diabetic patients (N = 6)
Before
treatment
Mean values
of 600 and
Postexercise Postexercise first
Period 1 Period 2 postexercise
32.5 43.2e 61.5 70.5"
(3.8 to 115.0) (6.3 to 187.3)
4.2 1.8h 3.7 l.8 3.9 2.5 8.4 4.lc 5.7 3.3k
(2.0 to 6.4) (0.8 to 6.4) (1.2 to 7.1) (3.3 to 13.2) (1.8 to 11.0)
a Values are the means so. Ranges are in parentheses. N denotes the number of subjects.
b p < 0.05, different before treatment.
'P < 0.025, different before treatment.
"P < 0.025, different pre-exercise.
a p < 0.05, different pre-exercise.
Pre-exercise
Periods
1+2
Mean value of
600 and first
postexercise
the same level at rest and during 450 kpmlmin, but it was
reduced after treatment at 600 kpm/min (P < 0.02, Table 4).
At rest BP showed a reduction in systolic level after treat-
ment (P < 0.01), but there was no difference in diastolic
pressure. During the exercise loads no significant fall in systolic
pressures was noted after treatment.
During graduated exercise
Results regarding albumin and beta-2-microglobulin excre-
tion rates before and during graduated exercise are shown in
Tables 5 and 6. The control subjects showed an exercise-
induced increase in albumin excretion at 1200 kpm/min while
beta-2-microglobulin excretion was undisturbed during exer-
cise. Three of ten control persons developed increase in albu-
min excretion at 900 kpm/min. However, the difference was not
statistically significant. All the ten control persons increased at
1200 kpmlmin indicating that the normal person has to exercise
on very hard levels in those short-term experiments before the
increase appears. None of the persons showed an increase in
beta-2-rnicroglobulin excretion as shown in Table 6.
For the 11 diabetic patients an earlier increase in albumin
excretion was noted. One single patient showed only enhance-
ment of albumin excretion at 1200 kpm/min (diabetes duration
of 4 years) and another patient only at 900 and 1200 kpm/min
(diabetes duration of 6 years); all the others exhibited an
increase in albumin excretion at lower exercise levels. As
shown in Table 5 there are significant differences between the
diabetic and normal groups from 600 kpm/min to 900 kpm/min
(P <0.01). A significant difference was not established at 1200
kpm/min when both groups had high excretion rates.
Height Weight
cm kg
10 26.8 3.2
Il 28.3±4.6
6 23.8 4.3
183 4
179 4
73 4
73 5
182±3 65±5
Pre-exercise At 450 At 600
Group Periods 1+2 kpm/min kpm/min
After
6 to 15 days of treatment
16.1 25.2 30.3 34.4 49.5 79.8' 89.9 92.4"
(3.0to67.2) (l.9to82.0) (3.8to 168.5) (12.9to206.0)
5.0 3.1'
(1.4 to 10.2)
Group
Table 3. Beta-2-microglobulin excretion (ng/min) before and after insulin treatment"
At 450 At 600 Postexercise Postexercise
kpm/min kpm/min Period I Period 2
Diabetic patients (N = 5)
Before 70 52 55 29 31 12 79 43 97 106 67 25
treatment (18 to 156) (25 to 95) (19 to 43) (41 to 126) (22 to 279) (30 to 88)
(Patient no. 6)" 8334 7800 11875 4970 9600 8423
(N = 6)
After 77 38 50 27 40 24 57 17 73 21 65 31
6 to 15 days of treatment (41 to 141) (23 to 88) (9 to 68) (33 to 73) (46 to 93) (37 to 119)
a Values are the means so. Ranges are in parentheses. N denotes the number of subjects.
b Patient no. 6 had very high values before treatment and normal values after treatment.
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Table 4. Heart rate and BP (mm Hg) before and after insulin treatment"
Pre-exercise At 450 kpmlmin At 600
BP
Group Heart rate Systolic Diastolic Heart rate BP systolic Heart rate
kmp/min
BP systolic
Diabetic patients (N = 6)
Before 64 5 123 7 76 11 119 16 145 13 154 21 158 15
treatment (56to68) (ll5to 130) (60to90) (lO6to 144) (l3Oto 165) (133to 184) (l4Otol8O)
After 63 4 108 35 73 7 114 10 133 9 136 14" 150 13
6 to 15 days of treatment (58 to 68) (105 to 110) (65 to 80) (101 to 130) (120 to 145) (120 to 154) (130 to 165)
"Values are the means SD. Ranges are in parentheses. N denotes the number of subjects.b < 0.01, different before treatment.
"P < 0.02, different before treatment.
Table 5. Albumin excretion (gImin) before and during graduated exercise"
At 300 At 450 At 600 At 750 At 900 At 1200
Group Before exercise kpmlmin kpmlmin kpm/min kpmlmin kpm/min kpmlmin
Normal subjects 7.0 4.4 6.4 4.0 6.8 3.5 6.7 3.2 6.4 2.6 15.8 18.3 147.6 l56.6b(N = 10) (2.7 to 16.2) (1.8 to 14.0) (2.3 to 14.0) (2.9 to 11.9) (3.1 to 10.1) (3.7 to 65.0) (18.5 to 507.5)
Diabetic patients 5.6 2.5 4.7 2.7 6.6 4.2 13.4 ll.lcd 26.5 35.2hd 59.5 59.8hd 241.2 238.3k
(N = 11) (3.6 to 12.1) (2.0 to 12.0) (3.5 to 16.4) (4.2 to 56.4) (4.0 to 118.5) (5.3 to 197.8) (12.7 to 512.0)
"Values are the means SD. Ranges are in parentheses. N denotes the number of subjects.
5P < 0.01, different from pre-exercise values.
"P < 0.02, different from pre-exercise values.
d < 0.01, different from normal values.
Table 6. Beta-2-microglobulin excretion (ng/min) before and during graduated exercise"
At 300 At 450 At 600 At 750 At 900 At 1200
Group Before exercise kpmlmin kpmlmin kpmlrnin kpmlmin kpm/min kpm/min
Normal subjects 81 42 80 42 117 143 65 23 75 21 112 119 89 41(N = 8) (44 to 173) (45 to 180) (46 to 408) (41 to 95) (54 to 107) (51 to 403) (39 to 147)
Diabetic patients 65 20 61 27 55 30 65 25 72 19 85 29 375 454b
(N = 11) (29 to 100) (19 to 104) (20 to 103) (26 to 113) (43 to 100) (48 to 143) (86 to 1.383)
"Values are the means sn. Ranges in parentheses. N denotes the number of subjects.
b < 0.01, different from pre-exercise values.
"P < 0.025, different from normal values.
Beta-2-microglobulin excretion showed nø increase in the
diabetic patients, except for 1200 kpm/min.
Hemodynamics. Heart rate and BP showed no difference
between diabetic and normal persons at rest, (Tables 7 and 8).
The individual maximal heart rate measured separately on a
short exercise test with increasing work loads reaching the
maximal increased pulse rate showed no difference between the
two groups: diabetic patients, 184 beats/mm 6 (SD) and
normal persons, 187 beats/mm 6 (SD) (Table 7). During the
graduated exercise test, the pulse rate showed a significant
difference between the two groups at 300 kpm/min and at 900
kpm/min (P < 0.01). There was a borderline difference at 600
kpmlmin (P  0.05) but no difference at 450, 750, or 1200
kpm/min.
The BP at rest and during the graduated exercise test showed
no significant difference between the two groups, although
there was a tendency to higher values in the diabetic patients.
It was not possible to show a correlation between the
hemodynamic results and those for albumin excretion.
Discussion
The results of this study demonstrated the importance of the
metabolic control of kidney function when evaluated by a
provocation test of exercise-induced albuminuria. Koivista,
Huttunen, and Vierikko [11] and Viberti et al [12] have also
shown that abnormal albumin excretion during exercise is
corrected after strict metabolic control using continuous subcu-
taneous insulin infusion in patients who already take insulin
treatment. This study showed that newly diagnosed, untreated,
diabetic patients have an increased exercise-induced albumin-
uria, which is reversible to normal values after 6 to 15 days of
ordinary insulin treatment. Earlier studies have shown that
patients with a diabetes' duration of less than 1 year had normal
values of albumin excretion without an increase during exercise
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Table 7. Heart rate before and during graduated exercisea
At 300 At 450 At 600 At 750 At 900 At 1200
Group Before exercise kpm/min kpm/min kpm/min kpm/min kpm/min kpmlmin Maximal heart rate
Normal subjects 63 6 91 9 102 8 118 11 133 8 144 15 172 14
(N = 10) (52 to 72) (80 to 100) (90 to 115) (103 to 132) (120 to 140) (116 to 166) (144 to 192)
Diabetic patients 65 6 101 6b 108 7 129 7c 143 10 163 12' 177 5
(N = 11) (56 to 77) (89 to 108) (96 to 122) (120 to 142) (131 to 168) (141 to 188) (170 to 182)
187 6
(178 to 200)
184 6
(178 to 196)
Values are the means SD. Ranges are in parentheses. N denotes the number of subjects.
b P < 0.01, different from normal values.
P < 0.05, different from normal values.
Table 8. BP (mm Hg) before and during graduated exercises
Before exercise At 300 At 450 At 600 At 750 At 900 At 1200
Group Systolic Diastolic kpm/min, systolic pressure
Normal subjects 113 5 80 5 133 12 138 10 150 12 163 16 176 14
(N = 10) (105 to 120) (75 to 85) (115 to 140) (125 to 155) (135 to 165) (150 to 185) (160 to 195)
Diabetic patients 116 5 81 5 138 7 141 9 162 17 177 17 186 15
(N = 11) (110 to 125) (75 to 90) (130 to 150) (130 to 155) (140 to 195) (155 to 210) (170 to 215)
189 22
(155 to 220)
191 16
(160 to 210)
Values are the means SD. Ranges are in parentheses. N denotes the number of subjects.
[2]. In newly diagnosed patients used in this study the tubular
protein reabsorption, measured by beta-2-microglobulin excre-
tion, was generally undisturbed at rest and during exercise,
both before and alter treatment. One patient had very high
baseline excretion rates both in beta-2-microglobulin and in
albumin, as well as increases in albumin excretion during
exercise. However, this patient was also normalized completely
after insulin treatment.
Systolic BP at rest was reduced by 15 mm Hg in the mean (P
<0.01), but during exercise there were no differences. Earlier
CarlstrOm and Karlefors [13] were unable to demonstrate a
systolic BP change in newly diagnosed diabetic patients before
ordinary insulin treatment. Viberti et al found no systolic BP
changes alter the continuous subcutaneous insulin infusion
during exercise [12]. In this study the heart rate of all patients
was reduced during exercise at 600 kpm/min after the treatment
(P < 0.02). Viberti et al found similar results during an exercise
after continuous subcutaneous insulin infusion [12].
Thus, three studies show that better metabolic control can
correct the exercise-induced albuminuria in diabetic patients. It
should be noted that the blood glucose is not normalized in this
study; the mean value was 160 mg/dl which is in contrast to
Koivisto, Huttunen, and Vierikko [11] and Viberti et al [12] who
used the infusion pump of the subcutaneous type, obtaining
nearly normal blood glucose concentrations. The duration of
diabetes mellitus was much less in our patients.
Initially, 450 and 600 kpm/min for 20 mm each were used as
the work loads. In the present study the effect of other work
loads, both in normal persons and diabetic patients, were also
evaluated. The results in normal young males showed that
albuminuria after short-term exercise first appear at very hard
levels such as 1200 kpm/min with a tendency to increase at 900
kpm/min, whereas the diabetic patients showed an increase at
600 kpm/min and higher levels. The difference was significant
for 600, 750, and 900 kpm/min but not for 1200 kpmlmin.
The results of the graduated exercise show that the work load
of 750 kpmlmin is the level at which the difference in the
albumin excretion rate between the normal persons and diabetic
patients and for the diabetic patients is most pronounced. Also,
at this level heart rate and BP showed no difference between
diabetic patients and normal persons.
At the very hard work load of 1200 kpm/min pulse rate
increases to near maximal heart rate. This finding is interesting
in relation to the study of Poortmans, Dewancker, and Dorchy
[14], who examined a group of juvenile diabetic patients and a
comparable control group exercising until exhaustion. They
found no difference between the groups in the increase of
albumin excretion alter exercise, which agrees with our study's
observation made at 1200 kpm/min. It can be concluded that a
moderate work load should be used.
Beta-2-microglobulin excretion did not increase during exer-
cise up to 900 kpmlmin either for the diabetic group, or for the
normal group. At 1200 kpm/min a small increase was noted in
the diabetic patients but not in the normal persons. Thus, the
increase in albumin excretion is clearly of glomerular origin in
both groups and only with a slight tubular involvement at 1200
kpm/min in the diabetic patients.
The hemodynamic response to exercise was the same for the
BP in both groups. Karlefors [15] showed that moderate to hard
work loads increase systolic BP in long-term juvenile diabetic
patients and mainly in those with overt nepbronathy as indicat-
ed by proteinuria. This study included t-term diabetic
patients with normal values of albumin excretion at rest. Heart
rate was increased in the diabetic patients at some exercise
levels. However, there was no correlation between increase in
heart rate and albumin excretion. Maximal heart rate in the
groups was at the same level in both groups, indicating the same
working capacity.
It is concluded that the observed abnormal albuminuria in
diabetes during exercise is due to glomerular abnormalities and
Exercise-induced albuminuria in diabetes 729
is dependent upon the metabolic state as well as the duration of
diabetes.
The exact mechanism producing the abnormal albuminuria
during exercise remains to be clarified. The mechanism may
well be different in different situations in diabetic patients.
Thus, in the untreated patients, an abnormally high intraglomer-
ular pressure may operate to produce an abnormal permeability
to proteins. During standard treatment, albumin excretion
during exercise becomes normal during the first years of
diabetes mellitus, thereafter, it increases again. The mechanism
in this situation after some years of diabetes probably involves
abnormal structure of the glomerular basement. The increase in
intraglomerular pressure during exercise is not necessarily
higher than that found in normal persons, but it is suggested that
due to abnormal intrinsic structure the glomerular membrane,
probably the basement membrane, becomes leaky during the
provocation test and results in albuminuria.
Summary. The effect of diabetes control and the level of work
loads on the exercise-induced increase in urinary albumin
excretion was investigated in young insulin-dependent male
diabetic patients. Radioimmunoassay was used for measuring
albumin and beta-2-microglobulin excretion. Before and after
insulin treatment six patients were studied. Work loads in this
part of the study were 450 followed by 600 kpm/min on a bicycle
ergometer for 20 mm each at which loads no increase in albumin
or beta-2-microglobulin were found in normal persons. At the
onset of diabetes, exercise induced an abnormal increase in
albumin excretion, 16.1 .g/min 25.2 (SD) — 61.5 ig/min
70.5 (SD), before treatment of insulin, reversible to 4.2 g/min
1.8 (sD)—* 5.0 .tg/min 3.1 (SD), and after insulin treatment for
6 to 15 days. No increase was found in beta-2-microglobulin
excretion. Using graded exercise loads, namely 300, 450, 600,
750, 900, and 1200 kpm/min for 20 mm each, it was found that 11
young male nonobese juvenile diabetic patients in ordinary
diabetic control and with a mean diabetes' duration of 10 years
6 (SD) showed an increase in albumin excretion at smaller
work loads compared to 10 young male control persons. Com-
pared to baseline values, which were normal, the diabetic
patients exhibited a significant increase at 600, 750, 900, and
1200 kpm/min, whereas the control persons showed an increase
only at 1200 kpm/min. Significant differences between the
groups, diabetic patients and the control persons in albumin
excretion, were demonstrated at 600, 750, and 900 kpmlmin.
Beta-2-microglobulin showed no increase and no difference
between the two groups indicating undisturbed tubular func-
tion, except at 1200 kpm/min only at which level the diabetic
patients but not the normal persons exhibited increase. It is
concluded that the abnormal exercise-induced albumin excre-
tion in diabetes is due to glomerular abnormalities, is found at a
smaller work load than in normals, and is dependent upon the
metabolic state as well as duration of diabetes.
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